• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tumoral melanosis associated with combined / inhibition (dabrafenib/trametinib) in metastatic melanoma.

作者信息

Laino Antonia, Shepherd Benjamin, Atkinson Victoria, Fu Hong, Soyer H Peter, Schaider Helmut

机构信息

Dermatology Research Centre, The University of Queensland, The University of Queensland Diamantina Institute, Brisbane, Australia.

Department of Pathology, Princess Alexandra Hospital, Brisbane, Australia.

出版信息

JAAD Case Rep. 2018 Oct 10;4(9):921-923. doi: 10.1016/j.jdcr.2018.06.024. eCollection 2018 Oct.

DOI:10.1016/j.jdcr.2018.06.024
PMID:30320196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6180233/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/6180233/0c108581f6c6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/6180233/7580b0e45f3a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/6180233/0c108581f6c6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/6180233/7580b0e45f3a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/6180233/0c108581f6c6/gr2.jpg

相似文献

1
Tumoral melanosis associated with combined / inhibition (dabrafenib/trametinib) in metastatic melanoma.转移性黑色素瘤中与联合治疗（达拉非尼/曲美替尼）相关的肿瘤性黑变病。
JAAD Case Rep. 2018 Oct 10;4(9):921-923. doi: 10.1016/j.jdcr.2018.06.024. eCollection 2018 Oct.
2
Trametinib: a MEK inhibitor for management of metastatic melanoma.曲美替尼：一种用于治疗转移性黑色素瘤的MEK抑制剂。
Onco Targets Ther. 2015 Aug 25;8:2251-9. doi: 10.2147/OTT.S72951. eCollection 2015.
3
Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients.达拉非尼联合曲美替尼与维莫非尼联合考比替尼用于既往未治疗的转移性黑色素瘤患者的间接治疗比较
J Hematol Oncol. 2017 Jan 4;10(1):3. doi: 10.1186/s13045-016-0369-8.
4
Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAF-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial.达拉非尼联合曲美替尼治疗 BRAF 和 MEK 抑制剂预处理的晚期 BRAF 突变型黑色素瘤患者：一项开放标签、单臂、双中心、Ⅱ期临床研究。
Lancet Oncol. 2017 Apr;18(4):464-472. doi: 10.1016/S1470-2045(17)30171-7. Epub 2017 Mar 4.
5
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.新辅助加辅助达拉非尼和曲美替尼与高危可切除黑色素瘤患者的标准治疗相比：一项单中心、开放标签、随机、2 期临床试验。
Lancet Oncol. 2018 Feb;19(2):181-193. doi: 10.1016/S1470-2045(18)30015-9. Epub 2018 Jan 18.
6
Trametinib (MEKINIST°) Metastatic or inoperable BRAF V600-positive melanoma: a few extra months of life.曲美替尼（迈吉宁®）：用于治疗转移性或不可切除的BRAF V600阳性黑色素瘤，延长数月生命。
Prescrire Int. 2016 Dec;25(177):285-288.
7
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF(V600E) melanoma.BRAF和MEK抑制剂免疫疗法对BRAF（V600E）黑色素瘤的抗肿瘤活性增强
Sci Transl Med. 2015 Mar 18;7(279):279ra41. doi: 10.1126/scitranslmed.aaa4691.
8
Clinical and radiological response of BRAF inhibition and MEK inhibition in patients with brain metastases from BRAF-mutated melanoma.BRAF 突变型黑色素瘤脑转移患者中 BRAF 抑制和 MEK 抑制的临床及影像学反应
Melanoma Res. 2018 Apr;28(2):126-133. doi: 10.1097/CMR.0000000000000429.
9
Dabrafenib in combination with trametinib for the treatment of metastatic melanoma.
Expert Rev Clin Pharmacol. 2015 Jan;8(1):25-33. doi: 10.1586/17512433.2015.974556. Epub 2014 Dec 4.
10
Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAF (V600) Mutation.达拉非尼联合曲美替尼：治疗 BRAF(V600) 突变型晚期黑色素瘤的药物评价。
Target Oncol. 2016 Jun;11(3):417-28. doi: 10.1007/s11523-016-0443-8.

引用本文的文献

1
Tumoral Melanosis of the Colon: A Rare Manifestation of Regressed Melanoma.结肠肿瘤性黑素沉着症：消退性黑色素瘤的一种罕见表现。
ACG Case Rep J. 2025 Jun 5;12(6):e01717. doi: 10.14309/crj.0000000000001717. eCollection 2025 Jun.
2
Tumoral Melanosis: A Case Series of a Rare Clinical Entity.肿瘤性黑素沉着症：一种罕见临床实体的病例系列
Dermatol Ther (Heidelb). 2025 May;15(5):1259-1273. doi: 10.1007/s13555-025-01363-9. Epub 2025 Feb 25.
3
Tumoral melanosis mimicking residual melanoma in the setting of talimogene laherparepvec treatment.

本文引用的文献

1
Granulomatous Tumoral Melanosis Associated With Pembrolizumab Therapy: A Mimicker of Disease Progression in Metastatic Melanoma.与帕博利珠单抗治疗相关的肉芽肿性肿瘤性黑色素沉着症：转移性黑色素瘤中疾病进展的模仿者
Am J Dermatopathol. 2018 Jul;40(7):523-526. doi: 10.1097/DAD.0000000000001066.
2
Case of tumoral melanosis with a massive infiltration of CD163 and CD68 macrophages.伴有CD163和CD68巨噬细胞大量浸润的肿瘤性黑素沉着病病例。
J Dermatol. 2018 Mar;45(3):368-370. doi: 10.1111/1346-8138.13991. Epub 2017 Jul 24.
3
Tumoral Melanosis Associated with Pembrolizumab-Treated Metastatic Melanoma.
肿瘤性黑变病模拟替莫唑胺治疗后残留黑色素瘤。
J Immunother Cancer. 2022 Oct;10(10). doi: 10.1136/jitc-2022-005257.
4
Gray-black macules in a patient with melanoma.一名黑色素瘤患者身上的灰黑色斑疹。
JAAD Case Rep. 2022 Aug 23;28:113-115. doi: 10.1016/j.jdcr.2022.08.021. eCollection 2022 Oct.
5
Tumoral melanosis without metastasis: a report after three years of follow-up.无转移的肿瘤性黑素沉着症：三年随访报告
An Bras Dermatol. 2021 Nov-Dec;96(6):797-798. doi: 10.1016/j.abd.2020.04.016. Epub 2021 Sep 29.
6
Peritoneal melanosis associated with metastatic melanoma previously treated with targeted and immune checkpoint inhibitor therapy.与先前接受过靶向和免疫检查点抑制剂治疗的转移性黑色素瘤相关的腹膜黑色素沉着症。
BMJ Case Rep. 2021 Jan 11;14(1):e238235. doi: 10.1136/bcr-2020-238235.
与帕博利珠单抗治疗的转移性黑色素瘤相关的肿瘤性黑素沉着症
Cureus. 2017 Feb 13;9(2):e1026. doi: 10.7759/cureus.1026.
4
BRAF V600E Mutation in Involuting Nevus in a Patient Treated With Vemurafenib.接受维莫非尼治疗患者的消退痣中的BRAF V600E突变
JAMA Dermatol. 2017 Jun 1;153(6):605-607. doi: 10.1001/jamadermatol.2016.6091.
5
Extensive tumoral melanosis associated with ipilimumab-treated melanoma.与伊匹单抗治疗黑色素瘤相关的广泛肿瘤性黑色素沉着。
Br J Dermatol. 2016 Aug;175(2):391-3. doi: 10.1111/bjd.14474. Epub 2016 Mar 18.
6
BRAF Inhibitor-Induced Antitumoral Granulomatous Dermatitis Eruption in Advanced Melanoma.BRAF抑制剂诱发的晚期黑色素瘤抗肿瘤性肉芽肿性皮炎皮疹
Am J Dermatopathol. 2015 Oct;37(10):795-8. doi: 10.1097/DAD.0000000000000281.
7
Completely regressed primary cutaneous malignant melanoma with nodal and/or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria.伴有淋巴结和/或内脏转移的完全消退原发性皮肤恶性黑色素瘤：5例报告及文献与诊断标准评估
J Am Acad Dermatol. 2005 Jul;53(1):89-100. doi: 10.1016/j.jaad.2005.03.006.
8
Nodular melanosis due to epithelial neoplasms: a finding not restricted to regressed melanomas.上皮性肿瘤所致的结节性黑色素沉着症：一种不仅限于消退性黑色素瘤的表现。
Am J Dermatopathol. 1998 Apr;20(2):118-22. doi: 10.1097/00000372-199804000-00002.